144 related articles for article (PubMed ID: 26062422)
1. [Nuclear protein 1 knockdown inhibits proliferation and migration of HepG2 cells].
Huang H; Zhang Y; Wang X; Zhou X; Li S; Wang M; Ren J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jun; 31(6):782-6. PubMed ID: 26062422
[TBL] [Abstract][Full Text] [Related]
2. NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance.
Emma MR; Iovanna JL; Bachvarov D; Puleio R; Loria GR; Augello G; Candido S; Libra M; Gulino A; Cancila V; McCubrey JA; Montalto G; Cervello M
Cell Death Dis; 2016 Jun; 7(6):e2269. PubMed ID: 27336713
[TBL] [Abstract][Full Text] [Related]
3. [Knockdown of nuclear protein 1 (NUPR1) gene inhibits proliferation and promotes apoptosis of human multiple myeloma U266 cells].
Zeng C; Yi B; Li X; Chen J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2017 Sep; 33(9):1240-1246. PubMed ID: 29089084
[TBL] [Abstract][Full Text] [Related]
4. Lentivirus-mediated RNAi knockdown of NUPR1 inhibits human nonsmall cell lung cancer growth in vitro and in vivo.
Guo X; Wang W; Hu J; Feng K; Pan Y; Zhang L; Feng Y
Anat Rec (Hoboken); 2012 Dec; 295(12):2114-21. PubMed ID: 22961798
[TBL] [Abstract][Full Text] [Related]
5. Hepatitis B virus X promotes hepatocellular carcinoma development via nuclear protein 1 pathway.
Bak Y; Shin HJ; Bak Is; Yoon DY; Yu DY
Biochem Biophys Res Commun; 2015 Oct; 466(4):676-81. PubMed ID: 26392315
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of NUPR1 inhibits the proliferation of glioblastoma cells via ERK1/2, p38 MAPK and caspase-3.
Li J; Ren S; Liu Y; Lian Z; Dong B; Yao Y; Xu Y
J Neurooncol; 2017 Mar; 132(1):15-26. PubMed ID: 28000106
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of NUPR1 inhibits the growth of U266 and RPMI8226 multiple myeloma cell lines via activating PTEN and caspase activation‑dependent apoptosis.
Zeng C; Li X; Li A; Yi B; Peng X; Huang X; Chen J
Oncol Rep; 2018 Sep; 40(3):1487-1494. PubMed ID: 30015974
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of nuclear protein-1 induces cell cycle arrest in G0/G1 phase in glioma cells in vivo and in vitro via P27.
Li J; Lian ZG; Xu YH; Liu RY; Wei ZQ; Li T; Lv HT; Zhao YS; Liu YJ; Dong B; Fu X
Neoplasma; 2020 Jul; 67(4):843-850. PubMed ID: 32266819
[TBL] [Abstract][Full Text] [Related]
9. Short hairpin RNA-mediated knockdown of nuclear factor erythroid 2-like 3 exhibits tumor-suppressing effects in hepatocellular carcinoma cells.
Yu MM; Feng YH; Zheng L; Zhang J; Luo GH
World J Gastroenterol; 2019 Mar; 25(10):1210-1223. PubMed ID: 30886504
[TBL] [Abstract][Full Text] [Related]
10. Loss of ATOH8 Increases Stem Cell Features of Hepatocellular Carcinoma Cells.
Song Y; Pan G; Chen L; Ma S; Zeng T; Man Chan TH; Li L; Lian Q; Chow R; Cai X; Li Y; Li Y; Liu M; Li Y; Zhu Y; Wong N; Yuan YF; Pei D; Guan XY
Gastroenterology; 2015 Oct; 149(4):1068-81.e5. PubMed ID: 26099525
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA AK021443 Promotes Cell Proliferation and Migration by Regulating Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma Cells.
Yang J; Li J; Liu B; Zhang R; Gu F; Zhao J; Cheng S
DNA Cell Biol; 2018 May; 37(5):481-490. PubMed ID: 29638164
[TBL] [Abstract][Full Text] [Related]
12. A novel all-trans retinoic acid derivative 4-amino‑2‑trifluoromethyl-phenyl retinate inhibits the proliferation of human hepatocellular carcinoma HepG2 cells by inducing G0/G1 cell cycle arrest and apoptosis via upregulation of p53 and ASPP1 and downregulation of iASPP.
Liu H; Chen F; Zhang L; Zhou Q; Gui S; Wang Y
Oncol Rep; 2016 Jul; 36(1):333-41. PubMed ID: 27177208
[TBL] [Abstract][Full Text] [Related]
13. NUPR1 participates in YAP-mediate gastric cancer malignancy and drug resistance via AKT and p21 activation.
Jiang L; Wang W; Li Z; Zhao Y; Qin Z
J Pharm Pharmacol; 2021 Apr; 73(6):740-748. PubMed ID: 33793788
[TBL] [Abstract][Full Text] [Related]
14. High expression of G-protein signaling modulator 2 in hepatocellular carcinoma facilitates tumor growth and metastasis by activating the PI3K/AKT signaling pathway.
He XQ; Zhang YF; Yu JJ; Gan YY; Han NN; Zhang MX; Ge W; Deng JJ; Zheng YF; Xu XM
Tumour Biol; 2017 Mar; 39(3):1010428317695971. PubMed ID: 28347229
[TBL] [Abstract][Full Text] [Related]
15. Effects of TMEM9 gene on cell progression in hepatocellular carcinoma by RNA interference.
Zhang Y; Ran Y; Xiong Y; Zhong ZB; Wang ZH; Fan XL; Ye QF
Oncol Rep; 2016 Jul; 36(1):299-305. PubMed ID: 27220462
[TBL] [Abstract][Full Text] [Related]
16. [Knockdown of STAT3 inhibits proliferation and migration of HepG2 hepatoma cells induced by IFN1].
Li X; Wang Y; Yan B; Fang P; Ma C; Xu N; Fu X; Liang S
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2018 Feb; 34(2):115-122. PubMed ID: 29673453
[TBL] [Abstract][Full Text] [Related]
17. [Knockdown of Aurora-A inhibits proliferation and promotes apoptosis of HepG2 hepatocellular carcinoma cells].
Li Z; Han S; Liu B; Bu W; Liu D; Yan H; Liu Q
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Mar; 37(3):233-239. PubMed ID: 33766231
[TBL] [Abstract][Full Text] [Related]
18. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling.
Qiu FN; Huang Y; Chen DY; Li F; Wu YA; Wu WB; Huang XL
World J Gastroenterol; 2016 Apr; 22(16):4226-37. PubMed ID: 27122673
[TBL] [Abstract][Full Text] [Related]
19. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
Wu WL; Wang WY; Yao WQ; Li GD
Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
[TBL] [Abstract][Full Text] [Related]
20. Induction of NUPR1 and AP‑1 contributes to the carcinogenic potential of nickel.
Murphy A; Roy N; Sun H; Jin C; Costa M
Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
